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Immunohistochemistry has become a practical and widely used tool for diagnosis in human pathology 
since the 70's. However, its application in veterinary diagnostic pathology has not been so common, 
especially due to the lack of specific antibodies. To overcome this drawback, antibodies which present 
cross reactivity with human and animal antigens have been applied. The purpose of the present study 
was to test the cross reactivity of some antibodies intended for the human pathology, which may be used 
in animal tissues, with the help of antigen retrieval and amplification systems. In the present study it was 
confirmed that many of the antibodies produced for use in human histopathology might be applied in 
veterinary pathology. Further studies are needed to increase the list of applicability of these antibodies 
to different animal species. It must be stressed that in this type of study some variables, such as clone 





A técnica de imuno-histoquímica é usada na rotina diagnóstica e na pesquisa em patologia humana desde 1970, 
porém seu uso na patologia veterinária é relativamente recente, principalmente com objetivo diagnóstico. A maior 
dificuldade no uso da imuno-histoquímica na patologia veterinária tem sido a falta de anticorpos específicos 
para os tecidos animais. Na falta de anticorpos específicos para as espécies domésticas, a patologia veterinária 
freqüentemente faz uso de anticorpos que apresentam reatividade cruzada entre antígenos humanos e animais. 
O objetivo deste trabalho foi testar a reatividade cruzada de diversos anticorpos feitos para uso humano em 
tecido parafinado de algumas espécies animais, utilizando-se dos novos métodos de recuperação antigênica e 
amplificação da reação imuno-histoquímica. No presente estudo foi possível confirmar a aplicabilidade de que 
muitos anticorpos produzidos para diagnóstico imuno-histoquímico em patologia humana podem ser utilizados 
em patologia veterinária. Novos estudos são necessários a fim de se ampliar a lista de aplicabilidade desses 
anticorpos em diferentes espécies animais, levando sempre em consideração as variações de clones, diluições, 
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a more accurate diagnosis. This fact has brought to the 
attention of veterinary pathologists the need to improve the 
application of immunohistochemistry in their daily routine, 
following the tendency of human diagnostic pathology.
The purpose of the present study is to test the cross 
reactivity of some antibodies intended for the human 
pathology, which may be used in animal tissues, with the 
help of antigen retrieval and amplification systems.
Material and methods
All cases tested in the present study were obtained 
from the files of the Department of Veterinary Pathology, 
Faculdade de Ciências Agrárias e Veterinárias of Universidade 
Estadual Paulista (UNESP/Jaboticabal) and from the 
Laboratory of Experimental Pathology of Campinas, São 
Paulo, Brazil. Tissues used, animal source and number of 
cases are summarized in Table 1. The cases and species 
included in the present study corresponded either to those 
which presented diagnostic problems (more frequently), or 
to those which served as tests for future research projects.
Immunohistochemistry
Serial sections were placed on silanized slides and 
dewaxed. Antigen retrieval was performed after hydration 
and endogenous peroxidase blocking with 3% H2O2 in a 
steamer (T-Fal®, France) at 90° C for 30 minutes. The slides 
were then incubated overnight (18 hours) at 4° C with the 
primary antibodies specified in Table 2. The detection 
systems for each primary antibody were used according 
to the suppliers’ instructions (two polymer-based detection 
systems, EnVision [K1491; Dakocytomation, Carpenteria, 
CA, USA] and EnVision Plus [K4001, Dako], and a catalyzed 
signal amplification system, CSA [K1500; Dako], were used, 
as also listed in Table 2). Labeling was visualized with 3,3’-
diaminobenzidine (D-5637; Sigma, St. Luis, MO, USA) 
added to H2O2 3% in phosphate-buffered saline (pH 7.6). 
Positive controls consisted of human tissues known to be 
reactive for each marker. Negative controls were performed 
by replacing the primary antibody by bovine serum albumin 
(BSA 1% in phosphate-buffered saline, pH 7.6) in the animal 
samples. Immunolabeling was evaluated microscopically.
Results
The description of immunolabeling for each marker 
is described in Table 3 and some examples are shown in 
Figures 1 to 8.
Introduction
Immunohistochemistry has become a practical and 
widely used tool for diagnosis in human pathology since 
the 70's. However, its application in veterinary diagnostic 
pathology has not been so common, especially due to the 
lack of specific antibodies. To overcome this drawback, 
antibodies which present cross reactivity with human and 
animal antigens have been applied. Other limitations of the 
method are represented by antigen masking by formalin 
fixation, reducing specific antigen-antibody binding(4, 17, 21).
In this respect, an extraordinary progress has been achieved 
with the production of a wide variety of monoclonal 
antibodies to epitopes resistant to formalin fixation, thanks to 
the hybridoma technology, with the use of antigen retrieval 
methods and powerful amplifying systems. These are 
generally streptavidin-biotin based systems (e. g., labelled 
streptavidin biotin [LSAB], catalysed signal amplification 
[CSA]) or polymer-based systems (e.g., EnVision), which 
may amplify the signal of immunohistochemical reaction up 
to 200 fold(19). All this has allowed cross reactivity of some 
antibodies produced for human antigens with formalin-
fixed, paraffin-embedded animal tissues.
Veterinary medicine has progressively improved its 
therapeutic spectrum, especially in oncology, demanding 


















Mesothelioma Bruin (Ursus arctos 
middendorffi)
1
Reactive lymph node Dog, bovine, 
monkey (sagüi una)
10
Normal lung Dog 1
TVT: transmissible venereal tumor.
Tabela 1
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Specification of antibodies used in the present study
Antibody Supplier Clone Dilution Amplification
system
Tissue Animal
T-cell, CD3 Dako PC3/188A 1:50 EnVision Lymph node Dog
T-cell, CD3 Novocastra PS1 1:50 EnVision Lymph node Dog, bovine
T-cell, CD8 Novocastra 1A5 1:40 EnVision Lymph node Monkey
T-cell, CD8 Novocastra 1A5 1:800 CSA Lymph node Monkey
T-cell, CD8 Dako C8/144B 1:50 EnVision Lymph node Monkey
B-cell, BLA-36 Novocastra A2742 1:50 CSA/Envision Lymph node Dog, bovine
B-cell, CD79a Dako HM57 1:50 CSA/EnVision Lymph node Dog
CD117, c-kit Dako Polyclonal 1:50 EnVision Mastocytoma Dog
CD31 Dako JC70A 1:10 EnVison Hemangiosar-
coma
Dog
Lysozyme Dako Polyclonal 1:400 EnVision Cutaneous 
histiocytoma
Dog





Dako Polyclonal 1:50 EnVision Skin Dog
NSE Dako BBS/NC/VI
H14
1:100 EnVision Neuroendocrine 
tumor
Dog
Sinaptofisin Dako Polyclonal 1:50 EnVision Neuroendocrine 
tumor
Dog
S-100 protein Dako Polyclonal 1:800 EnVision Melanoma Dog
Melanocytic antigen, 
HMB45
Dako HMB35 1:10 EnVision Melanoma Dog
Vimentin Dako V9 1:50 EnVision Melanoma, 
mesothelioma
Dog, bear
PLAP Dako 8A9 1:50 EnVision Seminoma Dog
TTF-1 Dako 8G7G3/1 1:50 EnVision Plus Lung Dog
p-53 protein Novocastra CM-1,
polyclonal
1:50 EnVision Lymphoma Dog





MIB-1 1:50 EnVision Plus TVT Dog
Proliferation antigen, 
Ki-S-5
Dako Ki-S-5 1:50 EnVision Plus TVT Dog
Proliferation antigen, 
Ki-67
Novocastra MM-1 1:50 EnVision Plus TVT Dog
PCNA Dako PC10 1:100 EnVision Mastocytoma Dog
PCNA Novocastra PC10 1:100 EnVision Mastocytoma Dog




Specific immunolabeling for each marker used in this study
Antibody Supplier Number of 
positive cases
Immunolabeling
T-cell, CD3 Dako 5/5 Intense, membrane of small lymphocytes in paracortical 
areas
T-cell, CD3 Novocastra 5/5 Intense, membrane of small lymphocytes in paracortical 
areas
T-cell, CD8 Novocastra 8/8 Weak when the Envision detections system was used. In-
tense with CSA detection system, membrane of scattered 
small lymphocytes in follicles and paracortical areas
T-cell, CD8 Dako 0/8 Not reactive
B-cell, BLA-36 Novocastra 10/10 Moderate, membrane of small lymphocytes and blasts in 
follicles and scattered lymphoid cells in paracortical areas
B-cell, CD79a Dako 10/10 Intense, transmembrane of small lymphocytes and blasts 
in follicles and scattered lymphoid cells in paracortical 
areas
CD117, c-kit Dako 9/9 Variable, cytoplasm of neoplastic mast cells, Golgi pattern
CD31 Dako 1/1 Moderate, cytoplasm of hemangiosarcoma cells
Lysozyme Dako 10/10 Intense, cytoplasm of histiocytes and granulocytes
Myeloperoxidase Dako 10/10 Intense, cytoplasm of granulocytes in a granular pattern
Pancytokeratin, 
AE1/AE3
Dako 4/4 Intense, cytoplasm of epithelial cells
NSE Dako 4/4 Moderate, cytoplasm of neuroendocrine cells
Sinaptofisin Dako 3/3 Moderate, cytoplasm of neuroendocrine cells
S-100 protein Dako 5/5 Intense, cytoplasm of mesenchymal cells
Melanocytic antigen, 
HMB45
Dako 0/4 Not reactive
Vimentin Dako 5/5 Intense, cytoplasm of mesenchymal cells
PLAPH Dako 1/1 Moderate, cytoplasm of seminoma cells
TTF-1 Dako 1/1 Intense, nuclei of pneumocytes
p-53 protein Novocastra 8/8 Intense, nuclei of neoplastic lymphoid cells
c-myc Dako 2/2 Variable; nuclei of TVT cells
Proliferation antigen, 
Ki-67
Immunotech 10/10 Intense, nuclei of TVT cells
Proliferation antigen, 
Ki-S-5
Dako 10/10 Intense; nuclei of TVT cells
Proliferation antigen, 
Ki-67
Novocastra 10/10 Intense; nuclei of TVT cells
PCNA Dako 10/10 Variable, nuclei of lymphocytes and mast cells
PCNA Novocastra 10/10 Variable, nuclei of lymphocytes and mast cells
NSE: neuron specific enolase; PLAPH: placental alkaline phosphatase; TTF-1: thyroid transcription factor; TVT: transmissible venereal tumor; PCNA: proliferating cell nuclear 
antigen.
Tabela 3
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Figure 8 – Mastocytoma, anti-proliferation marker Ki-67, nuclear staining (x 1.000)
Figure 2 – Neuroendocrine carcinoma, anti-neuron specific enolase (NSE), 
cytoplasm staining (x 800)
Figure 3 – Skin, anti-cytokeratin AE1/AE3, cytoplasm staining (x 800)
Figure 4 – Melanoma, anti-S100 protein, cytoplasm staining, (x 400)
Figure 1 – Mesothelioma, anti-vimentin, cytoplasm stainig (x 1.000) Figure 5 – Seminoma, anti-placental alkaline phosphatase (PLAP), cytoplasm 
staining (x 800)
Figure 6 – Lung (pneumocytes), anti-thyroid transcription factor-1 (TTF1), nuclear 
staining (x 800)
Figure 7 – Cutaneous histiocytoma, anti-lysozyme, cytoplasm staining (x 800)
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middendorffi) demonstrates the widespread preservation of 
this antigen in various species.
Lymphoid markers are largely used in human pathology 
and have been shown to cross react in various animal 
species(8, 9, 14, 22, 29, 30, 32). Nevertheless, the list of antibodies 
for use in veterinary pathology is still small. In 1993, Jones 
et al.(7) demonstrated cross reactivity of the antibody 
to CD3 in frozen sections of various domestic species, 
such as horses, bovines, pigs and chicken. This was later 
confirmed in formalin-fixed, paraffin-embedded material, 
using different detection and amplification methods(8). In 
our cases, CD3 was expressed in strong intensity in cell 
membrane of T lymphocytes of the species tested. Even 
the use of HIER and the polymer-based detection system 
did not allow higher dilution of the primary antibody, but 
no background unspecific reactivity was seen. Antibody to 
CD8 for use in animals is available only for frozen tissue(15).
The anti-human CD8 showed satisfactory immunolabeling 
in a hyperplastic monkey (sagüi una) lymph node. Another 
clone used (Dako, clone C8/144B) did not react, what 
stresses the need to test different suppliers and clones when 
the use in other species is intended. The cross reactivity 
of the pan-B antibodies to CD79a and BLA-36 has already 
been demonstrated(8). In our cases, reactivity for CD79a 
was more intense than for BLA-36, but a more sensitive 
detection system (CSA) was necessary for the first. A faint 
positivity in the muscular layer of blood vessels was also 
seen in specimens stained for CD79a, in accordance with 
previous reports(2).
Antibodies to lysozyme and myeloperoxidase labeled 
intensely histiocytes and myeloid cells of canine lymph 
nodes. The usefulness of these markers to differentiate 
histiocytic and myeloid neoplasms from lymphoma 
and other small cell neoplasia was demonstrated 
elsewhere(22).
The thyroid transcription factor (TTF-1) had already been 
shown to cross react with normal and neoplastic canine 
thyroid(16). The placental alkaline phosphatase (PLAPH) was 
not previously described in animal tumors. In our study, both 
were demonstrated in strong intensity in canine tissue, as 
compared with the positive human controls.
Reactivity of CD117/c-kit in cell membrane and 
cytoplasm was intense in our cases of canine mastocytoma, 
as previously described(10, 18, 25), confirming its utility in the 
identification of difficult cases. The polyclonal antibody to 
the p53 protein (Novocastra, clone CM1) showed strong 
nuclear reactivity, confirming the applicability of this 
marker in research and diagnostic veterinary pathology(5, 
Discussion
Most antibodies developed for animals are suitable 
for fresh tissue and have a limited application in routine 
veterinary histopathology. The most frequently used 
immunomarkers for animals in the routine diagnosis are 
polyclonal, as they contain antibodies to a wider range of 
epitopes, increasing sensitivity of the method, sometimes 
in detriment of specificity. Antigen retrieval techniques, 
especially the heat-induced ones, have been widely used 
in human pathology since the 80's, allowing reliable 
immunodetection of epitopes distorted by formalin 
fixation(4, 17, 21). These techniques have proven efficiency in 
routine veterinary pathology, permitting the utilization of a 
wider spectrum of markers, including monoclonal and those 
intended for human use, as shown by our results.
The polymer-based detection systems (e. g., EnVision and 
EnVision Plus) have increased sensitivity of immunoreactions 
and reduced one of its steps(19). In our study, this system 
has shown good results for most antibodies. However, in 
some cases, a signal amplification was needed (e. g., for 
the pan-B marker CD79a, as previously demonstrated by 
Sueiro et al.)(22). The catalyzed signal amplification system is 
very sensitive(19), but may result in unacceptable background 
staining. To overcome this adverse effect, thorough washing 
between the steps of the reaction and, sometimes, the over 
dilution of the primary antibody are necessary.
Antibodies to pancytokeratin AE1/AE3, neuron specific 
enolase (NSE), synaptofisin (SNF), S-100 protein and 
vimentin were previously described as showing cross 
reactivity in different animal species(17, 20, 31). Antibody to 
AE1/AE3 showed specificity in epithelial cells in our cases. 
The use of heat-induced epitope retrieval (HIER) and the 
polymer-based detection system were efficient, allowing a 
higher dilution of primary antibody and replacing the more 
imprecise method of enzymatic digestion, as previously 
reported(20).
The melanocytic antigen (Dako, clone HMB45) did not 
react in any test performed, using the same procedures 
described by Sulaimon et al.(27).
The antibodies to NSE and SNF also showed specific 
labeling, but in lesser intensity than the positive controls. 
This reinforces the need of testing different conditions of 
dilutions and reactions to adapt the use of antibodies for 
use in different animal species. Antibody to S-100 proteins 
showed intense cytoplasmic reactivity, accompanied 
by scattered nuclear positivity(24, 26). Strong labeling for 
vimentin in a case of mesotheliona of bruin (Ursus arctos 
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6, 10, 11, 18, 22, 23). Immunoexpression of c-myc was strong 
in the nuclei of the case of canine transmissible venereal 
tumor (TVT) tested in this study, corroborating previous 
reports(1, 35). This protein has also been demonstrated in 
canine breast tumors(6).
Amino acid sequences of proliferating cell nuclear antigen 
(PCNA) present high homology among mammalians, and 
also in superior vegetal(28). In our cases, nuclear reactivity 
for PCNA was strong, with faint cytoplasmic staining in 
mitotic cells(12, 34). In humans and animals, detection of the 
antigen Ki-67 has proven superior to PCNA in evaluation of 
proliferation index(3, 13, 33). In our experience, the best clone 
for application in canine pathology was MIB-1, as compared 
with MM-1 and Ki-S-5.
Conclusion
In the present study it was confirmed that many of 
the antibodies produced for use in human histopathology 
might be applied in veterinary pathology. Further studies 
are needed to increase the list of applicability of these 
antibodies to different animal species. It must be stressed 
that in this type of study, some variables, such as clone of 
antibody, dilution, antigen retrieval method, and detection 
system, have to be evaluated.
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